[1]杜原瑗,陈骞虎,贾绍辉,等.牛膝竹节参皂苷与杜仲松脂醇二葡萄糖苷联合治疗 骨质疏松性骨折的实验研究[J].中国中医骨伤科杂志,2015,23(06):9-13.
　DU Yuanyuan,CHEN Qianhu,JIA Shaohui,et al.Therapeutic Effect of Combined Chikusetsu Saponin of Achyranthes Bidentata Blume and Pinoresinol Diglucoside of Eucommia for Treating Osteoporotic Fracture[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2015,23(06):9-13.
点击复制

牛膝竹节参皂苷与杜仲松脂醇二葡萄糖苷联合治疗 骨质疏松性骨折的实验研究
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第23卷
期数:
2015年06期
页码:
9-13
栏目:
实验研究
出版日期:
2015-06-15

文章信息/Info

Title:
Therapeutic Effect of Combined Chikusetsu Saponin of Achyranthes Bidentata Blume and Pinoresinol Diglucoside of Eucommia for Treating Osteoporotic Fracture
文章编号:
1005-0205(2015)06-0009-05
作者:
杜原瑗1;  陈骞虎2;  贾绍辉3;  孙大明3;  汪学红3△
1.湖北省肿瘤医院(武汉,430079)
2.中国地质大学
3.武汉体育学院
△.通信作者 E-mail:wangxuehong555@163.com
Author(s):
DU Yuanyuan1;  CHEN Qianhu2;  JIA Shaohui3;  SUN Daming3;  WANG Xuehong3
1. Hubei Cancer Hospital, Wuhan 430079, China
2. China University of Geosciences
3. Wuhan Sports University
关键词:
牛膝竹节参皂苷;  杜仲松脂醇二葡萄糖苷;  骨质疏松性骨折
Keywords:
chikusetsu saponin;  pinoresinol diglucoside;  osteoporotic fracture
分类号:
R-33
文献标志码:
A
摘要:
目的:探讨牛膝有效成分牛膝竹节参皂苷与杜仲有效成分杜仲松脂醇二葡萄糖苷联合应用对骨质疏松性骨折的疗效及作用机理。方法:6月龄成年雌性Wistar大鼠随机分为3组:假手术对照组,模型组,治疗组。治疗组采用灌胃方式给予牛膝竹节参皂苷与杜仲松脂醇二葡萄糖苷混合溶液100 mg/(kg·d), 对照组和模型组给予同量的生理盐水。分别于2、4、6周处死模型鼠,取骨折端组织以及血清检测相关指标。结果:牛膝竹节参皂苷与杜仲松脂醇二葡萄糖苷联合应用治疗能够有效降低去卵巢Wistar大鼠骨质疏松性骨折模型血清中骨钙素(Bone Gla Protein, BGP)和碱性磷酸酶(Alkalin phosphatase, ALP)含量,显著上调骨折端护骨素(Osteoprotegerin, OPG)基因表达水平,但是明显下调骨形态发生蛋白-3(BMP-3)基因表达。结论:牛膝竹节参皂苷与杜仲松脂醇二葡萄糖苷联合应用能有效治疗雌激素缺乏所导致的大鼠骨质疏松性骨折。
Abstract:
Objective: To investigate the therapeutic effect and the mechanism of combined chikusetsu saponin of achyranthes bidentata blume and pinoresinol diglucoside of eucommia for treating the osteoporotic fracture(OPF). Methods: The Wistar rats of 6 months were divided into control group, model group and treatment group. The rats of treatment group were administered the mixture of chikusetsu saponin of achyranthes bidentata blume and pinoresinol diglucoside of eucommia(100mg/kg·d)by gavage. The rats of control group and model group were administered the same does of normal saline.The 2nd, 4th, and 6th weeks after treatment, the rats were sacrificed and the blood and the tissues at the fracture site were collected to detect the relevant index. Results: Combined using of chikusetsu saponin of achyranthes bidentata blume and pinoresinol diglucoside of eucommia could decreased the circulation BGP and ALP of ovariectomized osteoporosis rat, could significantly enhanced the expression of OPG mRNA in the tissues of fracture site, and could obviously down-regulated the expression of BMP-3 mRNA. Conclusion: Combined using of chikusetsu saponin of achyranthes bidentata blume and pinoresinol diglucoside of eucommia is effective for treating the OPF caused by estrogen deficiency.

参考文献/References:

[1] 马俊岭, 郭海英, 阳晓东. 骨质疏松症的流行病学概况[J]. 中国全科医学, 2009, 12(9): 1744-1746.
[2] Nanes MS, Kallen CB. Osteoporosis, Semin Nucl Med[J]. 2014, 44(6):439-450.
[3] 关怀. 骨质疏松的流行病学与危险度评价[J].国外医学:卫生学分册, 2002, 28(3):140-142.
[4] Liao Q, Liu SQ, Ming JH, et al. Clinical therapeutic effects of anterior decompression on spinal osteoporotic fracture and inflammatory cytokines[J]. Pak J Med Sci,2014, 30(5): 931-935.
[5] Foger-Samwald U, Patsch JM, Schamall D, et al. Molecular evidence of osteoblast dysfunction in elderly men with osteoporotic hip fractures[J]. Exp Gerontol, 2014, 57: 114-121.
[6] 罗辉霞. 治疗骨质疏松症药物的研究进展[J]. 实用心脑肺血管病杂志,2010, 18(8):1188-1190.
[7] 王志强,孙波. 中药治疗原发性骨质疏松的进展[J].中国中医骨伤科杂志, 2014, 22(1): 76-78.
[8] 谢金华, 徐敏, 冯新送. 防治绝经后骨质疏松症药物的临床疗效综述[J]. 广州中医药大学学报, 2004, 21(2): 156-160.
[9] 陈小忆, 罗承锋. 原发性骨质疏松症中医研究进展[J]. 中国中医骨伤科杂志, 2004, 12(2): 62-64.
[10] 于大永, 吕晓超, 史丽颖, 等. 牛膝中三萜皂苷抑制破骨细胞分化作用的研究[J]. 中国中医骨伤科杂志, 2011,19(3): 9-12.
[11] 王双燕, 丁林芬, 宋流东,等.杜仲化学成分研究[J]. 中药材, 2014, 37(5): 807-811.
[12] 张月锋,韩景献.骨质疏松动物模型研究进展[J]. 动物医学进展,2005; 26(3): 8-11.
[13] 王小宁, 王黎, 杨黎彬,等. 竹节参总皂苷的纯化方法研究[J]. 应用化工,2012, 41(5): 781-783.
[14] 郑雪,刘泽纬,丁来欣,等.杜仲叶中松脂醇二葡萄糖苷的提取分离及含量测定[J]. 食品科学,2012,33(6): 166-170.
[15] Ivaska KK, Kakonen SM, Gerdhem P, et al. Urinary osteocalcin as a marker of bone metabolism[J]. Clin Chem, 2005, 51:618-628.
[16] Lee YH, Rho YH, Choi SJ, et al. Predictors of bone mineral density and osteoporosis in patients attending a rheumatology outpatient clinic[J]. Rheumatol Int,2003, 23:67-69.
[17] 黄宏兴, 王光伟. 骨形态发生蛋白与骨质疏松症[J]. 中国组织工程研究与临床康复,2010, 14(50): 9409-9412.
[18] 宋兴贤. 骨形态发生蛋白的基础研究及临床应用[J].现代医药卫生; 2007,23(7):1003-1004.
[19] Sagar DR, Ashraf S, Xu LT, et al. Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. Basic and Translational Research. 2014, 73(1):1558-1565.

备注/Memo

备注/Memo:
收稿日期:2014-12-08
基金项目:湖北省自然科学基金资助(2011CDB312)
更新日期/Last Update: 2015-06-10